- Motley Fool•5 days ago
The biotech's stock took a hit due to disappointing midstage results for its experimental hepatitis C drug.
- Motley Fool•6 days ago
Despite a soaring market, these stocks fell. Find out why.
- Zacks•last month
Achillion (ACHN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ADA.F: Summary for ACHILLION PHARMACEUTICALS - Yahoo Finance
Achillion Pharmaceuticals, Inc. (ADA.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 3:47PM CEST
|Bid||3.06 x 43600|
|Ask||3.12 x 42000|
|Day's range||3.08 - 3.10|
|52-week range||2.89 - 8.24|
|PE ratio (TTM)||-6.86|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|